Compounds > tolvaptan
Page last updated: 2024-09-05

tolvaptan and Pregnancy

tolvaptan has been researched along with Pregnancy in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bhardwaj, G; Dai, DF; Daneshgar, N; Horstmann, MM; Lan, RS; Liang, PI; O'Neill, BT; Pack, L; Penniman, CM1
Evans, H; Gilbert, RD; Griffiths, M; Haq, MR; Nagra, A; Olalekan, K1
Awogi, T; Fujita, S; Hosoki, E; Ishiharada, N; Ishiyama, H; Ito, N; Miyatake, M; Morimoto, H; Morishita, K; Nakagiri, N; Oi, A; Ozaki, A; Senba, T; Shiragiku, T; Uesugi, T; Umezato, M1
Furukawa, M; Kashiyama, E; Umehara, K1

Other Studies

4 other study(ies) available for tolvaptan and Pregnancy

ArticleYear
Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations.
    Kidney international, 2022, Volume: 101, Issue:5

    Topics: Animals; Animals, Newborn; Female; Humans; Male; Mice; Mutation; Oligopeptides; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Pregnancy; Tolvaptan

2022
Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease.
    Pediatric nephrology (Berlin, Germany), 2017, Volume: 32, Issue:5

    Topics: Benzazepines; Edema; Female; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidney Function Tests; Parenteral Nutrition; Polycystic Kidney, Autosomal Dominant; Pregnancy; Receptors, Vasopressin; Tolvaptan; Treatment Outcome; TRPP Cation Channels; Young Adult

2017
Nonclinical safety profile of tolvaptan.
    Cardiovascular drugs and therapy, 2011, Volume: 25 Suppl 1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Pressure; Central Nervous System; CHO Cells; Cricetinae; Cricetulus; Diuretics; Dogs; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Femoral Artery; Guinea Pigs; Heart Rate; Ileum; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Peripheral Nervous System; Pregnancy; Rabbits; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Respiration; Stomach; Tolvaptan

2011
Nonclinical pharmacokinetics of a new nonpeptide V2 receptor antagonist, tolvaptan.
    Cardiovascular drugs and therapy, 2011, Volume: 25 Suppl 1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Bile; Dogs; Exhalation; Fasting; Feces; Female; Fetus; Humans; Lactation; Male; Maternal-Fetal Exchange; Mice; Pregnancy; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tolvaptan

2011